Pharma Capital
CompanyCurrent (p)Value (£)
GlaxoSmithKline (GSK) 1599.00 138,528,597
AstraZeneca (AZN) 4688.00 125,966,419
Shire (SHP) 4626.50 80,930,023
Hikma Pharmaceuticals (HIK) 1905.00 19,540,671
GW Pharmaceuticals (GWP) 735.00 17,046,576
Indivior (INDV) 320.90 6,894,151
Vectura (VEC) 140.00 5,409,725
BTG (BTG) 644.00 4,567,583
Abcam (ABC) 838.00 2,492,413
SkyePharma (SKP) 443.00 2,325,201
Clinigen Group (CLIN) 840.50 2,152,958
Dechra Pharmaceuticals (DPH) 1651.00 1,904,263
Mereo BioPharma (MPH) 302.50 1,244,291
Genus (GNS) 1720.00 1,161,929
Motif Bio (MTFB) 40.25 859,642
Hutchison China (HCM) 2935.00 361,181
OptiBiotix Health (OPTI) 72.75 283,246
Horizon Discovery Group (HZD) 209.50 238,803
Sarossa (SARS) 1.52 213,131
Circassia Pharmaceuticals (CIR) 98.00 209,831
Immupharma (IMM) 53.00 204,149
Vernalis (VER) 20.50 194,917
Allergy Therapeutics (AGY) 27.25 130,108
Oxford Biomedica (OXB) 4.70 119,623
Alliance Pharma (APH) 49.25 108,178
ReNeuron Group (RENE) 2.23 95,562
Amryt Pharma (AMYT) 22.00 79,400
Redx Pharma (REDX) 32.50 69,284
Angle (AGL) 52.50 69,087
Proteome Sciences (PRM) 5.03 67,614

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.